R&D Sponsored Trials and tribulations of drug development What does it take to establish new treatments for rare diseases?
R&D Turning the NHS into a world-leading R&D platform Lord James O'Shaughnessy sets out the basis of his forthcoming independent review.
Oncology Better balance of cancer treatment efficacy and toxicity The FDA Oncology Center of Excellence announced its Project Optimus draft guidance in January.
News UK launches review of clinical trials amid worrying decline Review comes after drug industry saw a 41% decline in new trial starts between 2017 and 2021.
Patients Caring for rare: Celebrating Rare Disease Day 2023 Rare Disease Day is observed annually on what is considered the rarest day of the year.
News Protocol violations gut Pfizer’s Lyme disease shot study 50% of US patients in the VALOR study of VLA15 will be discontinued from the trial.
Oncology ASCO 2026: AbbVie on ADCs, chemotherapy, and the future of o... For years, ADCs have been positioned as an important addition to the oncology toolkit. But, could they eventually replace chemotherapy altogether?
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
